Background: Studies from both humans and animals experiments have offered abundant evidence supporting that mountain sickness is associated with changes in autonomic nervous function (ANF), which can be measured by heart rate variability (HRV).
(HAPH). 1 Studies by Wu Tian Yi et al showed that the prevalence of HAPH is higher in children than adults in Qinghai, China, and the difference is more obvious with the increase of altitude. 2 There are currently no relevant clinical studies focusing on autonomic changes in HAPH. Research is limited to changes in ANF in acute mountain sickness. In the development of HAPH, due to the low-oxygen hypobaric environment and pulmonary vascular remodeling, the right heart load is aggravated, affecting the sympathetic and vagus nerves that innervate the heart, and disrupting the balance of cardiac autonomic nervous system regulation. This leads to arrhythmia, cardiac disease, and sudden death. Therefore, it is imperative to explore ANF for chronic mountain disease, especially chronic HAPH.
| MATERIALS AND METHODS

| Ethics statement
The current survey was officially implemented after approval from the Medical Ethics Committee of the People's Hospital of Tibet Autonomous Region, China (approval number, ME-TBHP-36). All subjects or their families fully understood the purpose and methods of the study, and provided signed informed consent. There were no health interventions involving the subjects. All individual data were anonymous prior to analysis. The subjects were all Tibetans living at altitudes >3000 m. The baseline data of each group of subjects are shown in Table 1 
| Study subjects and protocol
| Echocardiographic exam
| HRV exam
Subject information was collected using a 12-lead 24-hour full information DCG system (Holter, Del Mar Reynolds Medical, Lifecard CF).
Sampling requirements were: starting point at 9-11 AM and rest for 15 minutes before inspection. The DCG was recorded and replayed on a computer, excluding ventricular/supraventricular premature or other arrhythmias. The 24-hour continuous DCG was recorded, and the ventricular/supraventricular premature contraction and interference were automatically eliminated by the software. 
| HRV parameters
| HRV results
After adjustment for oxygen saturation (SaO 2 ), time domain indexes such as SDNN, SDANN, RMSSD, PNN50, and HRVTI progressively decreased from mild to severe groups of HAPH patients compared with control values, with statistically significant differences (P ≤ .001).
Similarly, after adjustment for SaO 2 , frequency domain indexes such as TP, VLF, LF, and HF progressively decreased from mild to severe groups of HAPH patients compared with control values, and the differences were statistically significant (P ≤ .001). In patients with mild pulmonary hypertension, the LF/HF ratio was slightly elevated compared with controls (P = .03). Meanwhile, this ratio was lowest in patients with moderate pulmonary arterial pressure followed by the severe diseased patients; both groups showed significantly lower LF/HF ratios compared with control values (P < .001). These data are detailed in Table 2 .
| Correlation between HRV index and elevated pulmonary arterial pressure
The mean values of each group were consistent with normal distribution, and the homogeneity test of variance showed that the variance was not uniform. The box charts of the average values for each index are shown in Figures S1-10 . The Kruskal-Wallis test was performed, and the results are shown in Table 3 , indicating that the difference in HRV between the groups was statistically significant. Next, Kendall
Rank correlation coefficients were determined. The results showed that time domain indexes including SDNN, SDANN, RMSSD, PNN50, and HRVTI, and frequency domain factors such as TP, VLF, LF, HF, and LF/HF were negatively correlated with pulmonary arterial pressure changes (P < .01) ( Table 4) . HRV is currently the most widely used method for the evaluation of ANF. As a noninvasive quantitative indicator for judging cardiac autonomic nervous activity, HRV has been confirmed by many clinical trials. 5, 6 It is used to evaluate a variety of cardiovascular diseases because of its noninvasive, simple, and reproducible characteristics. 7 More importantly, HRV is closely related to clinically meaningful outcome variables, such as heart events, morbidity, and mortality.
In the time domain of HRV, HRVTI represents the overall change of heart rate. SDNN and SDANN represent enhanced sympathetic activity. RMSSD and PNN50 represent weakened vagal activity, while RMSSD is more often used to evaluate vagal nerve function because of its good stability. The time domain analysis in this study was performed on a 24-hour time course, so assessment of long-term ANF in patients with HAPH is more accurate.
In this study, with the increase of pulmonary artery pressure, all time domain indexes of patients with HAPH were significantly reduced.
We observed a significant decrease in ANF in patients with chronic HAPH. HRV frequency domain analysis often uses short-term studies, so it is more suitable for short-term evaluation of ANF in patients with HAPH. The TP in the frequency domain represents the sum of high frequency, very low frequency, and ultralow frequency. LF was once used as a very important indicator of HRV to reflect the functional status of the sympathetic nerve. However, with further research, LF is no more considered an effective marker of autonomic nervous activity itself, because besides autonomic nervous system, it is also affected by baroreceptor activity. 8 HF reflects the excitability of the vagus nerve.
LF/HF representing the balance of autonomic nerves has been widely recognized. Short-term frequency domain analysis in this study showed that the increase of pulmonary artery pressure in patients with HAPH was negatively correlated with the changes of vagus nerve and sympathetic nerve. As pulmonary arterial pressure increased, the function of autonomic nerves was significantly attenuated. LF/HF increased in patients with mild HAPH, suggesting that ANF may be increased in patients with HAPH in the early stage of onset. In patients with moderate HAPH, LF/HF was the lowest, suggesting that autonomic function was significantly inhibited at this stage. There was a small increase in LF/HF in patients with severe HAPH, suggesting that autonomic function may be out of control at this stage.
In addition, studies in China have shown that the incidence of sinus tachycardia in patients with type I pulmonary hypertension mainly including idiopathic pulmonary hypertension, congenital heart disease-related pulmonary hypertension and connective tissue diseaserelated pulmonary hypertension can reach 26%. 9 According to the 2009 American College of Cardiology Foundation/American Heart Association's consensus on pulmonary hypertension, HAPH belongs to type III pulmonary hypertension. 10 In this study, we found that the average heart rate of patients with HAPH was significantly reduced, and this decrease was more pronounced with increasing pulmonary artery pressure. This may be related to the fact that the subjects selected were Tibetans living at high altitudes. Their adaptation to high altitude has obvious genetic basis. In the process of adapting to hypoxic and hypobaric natural environment, their dominant physiological adaptation is no longer the enhancement of respiratory and circulatory functions, but more dependent on organizational adaptation. The
Tibetans' ability to carry oxygen in circulation is enhanced, and oxygen is used more economically and effectively. Therefore, the compensatory increase of heart rate is not needed. Previous studies of healthy Tibetan adults living in Qinghai have also confirmed this point. 11
| Limitations
We used noninvasive methods to assess pulmonary artery pressure and cardiac function in this study. These methods tend to underestimate the level of pulmonary arterial pressure, which is not as accurate as invasive measurement methods. 12 For ethical reasons, invasive measurement methods cannot be used in healthy individuals. Although the effects of drugs and other factors have been excluded, in addition to the effects of HAPH, the effect of hypoxia on HRV cannot be ruled out, and the complexity of the relationship between the two is often inconsistent. Due to the complexity of the relationship between hypoxia and HRV, inconsistent results are often found in the literature. [13] [14] [15] [16] However, patients with chronic HAPH with an average duration of 5.00 (+0.65) years were selected in this study because they had achieved long-term adaptation to hypoxia. In general, hypoxia is considered to be effective in stimulating the sympathetic nervous system, resulting in a decrease in HRV variability (LF and HF components) and an increase in LF/HF ratios, which is inconsistent with the results of this study and fully demonstrates hypoxia in chronic altitude sickness. In this study, due to the limited sample size, we could not assess associations of HRV with hemoglobin levels and SaO 2 . Further validation studies are needed to verify these findings.
